Shares of Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $4.60 and last traded at $4.71, with a volume of 53475 shares. The stock had previously closed at $4.78.
Hypera Price Performance
The stock has a market cap of $2.90 billion, a P/E ratio of 8.97 and a beta of 1.04. The company has a 50 day simple moving average of $5.14 and a 200-day simple moving average of $5.38.
Hypera (OTCMKTS:HYPMY – Get Free Report) last released its earnings results on Thursday, July 25th. The company reported $0.15 earnings per share for the quarter. The firm had revenue of $420.00 million during the quarter.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Ride Out The Recession With These Dividend Kings
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
